DOSSIER · 13F Holders · Q2 2026Healthcare · In Vitro & In Vivo Diagnostic Substances
CLDX

CELLDEX THERAPEUTICS INC NEW

268 institutions still hold CELLDEX THERAPEUTICS INC NEW as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 15117B202·In Vitro & In Vivo Diagnostic Substances·268 13F holders·last filed Jun 30, 2026
Market cap
13F value held
$2.1B
visible holders
Holders
268
filers reporting
Concentration
16.88%
WELLINGTON MANAGEMENT GROUP LLP #1
top holder share
AI Holders Summary · Q2 2026

268 institutions reported CLDX in Q2 2026. WELLINGTON MANAGEMENT GROUP LLP leads at 16.9% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
WELLINGTON MANAGEMENT GROUP LLP
CIK 0000902219
$355M9.5M0.06%Q2 2026
02
BlackRock, Inc.
CIK 0002012383
$261M7.0M0.00%Q2 2026
03
Kynam Capital Management, LP
CIK 0001907884
$198M5.3M10.95%Q2 2026
04
STATE STREET CORP
CIK 0000093751
$145M3.9M0.00%Q2 2026
05
FMR LLC
CIK 0000315066
$139M3.7M0.01%Q2 2026
06
VANGUARD CAPITAL MANAGEMENT LLC
CIK 0002100119· Index
$129M3.5M0.00%Q2 2026
07
Deep Track Capital, LP
CIK 0001856083
$109M2.9M1.59%Q2 2026
08
Point72 Asset Management, L.P.
CIK 0001603466
$102M3.2M0.13%Q1 2026
09
Logos Global Management LP
CIK 0001792126
$78M2.1M3.36%Q2 2026
10
GEODE CAPITAL MANAGEMENT, LLC
CIK 0001214717· Index
$75M2.0M0.00%Q2 2026
11
Eversept Partners, LP
CIK 0001697013
$66M1.8M3.45%Q2 2026
12
PRICE T ROWE ASSOCIATES INC /MD/
CIK 0000080255
$66M2.1M0.01%Q1 2026
13
GOLDMAN SACHS GROUP INC
CIK 0000886982
$60M1.6M0.01%Q2 2026
14
Assenagon Asset Management S.A.
CIK 0001546007· Quasi-passive
$59M1.6M0.04%Q2 2026
15
Commodore Capital LP
CIK 0001831942
$50M1.4M2.99%Q2 2026
16
Bellevue Group AG
CIK 0001674546
$45M1.2M0.94%Q2 2026
17
MILLENNIUM MANAGEMENT LLC
CIK 0001273087
$44M1.2M0.02%Q2 2026
18
BRAIDWELL LP
CIK 0001920938
$43M1.4M1.43%Q1 2026
19
DIMENSIONAL FUND ADVISORS LP
CIK 0000354204· Quasi-passive
$40M1.1M0.01%Q2 2026
20
Vestal Point Capital, LP
CIK 0001974915
$39M1.2M1.09%Q1 2026
Page 1 of 14
248 more holders available. Log in →
Insiders at CELLDEX THERAPEUTICS INC NEW
Pepin RonaldCrowley ElizabethCavanaugh SarahMartin Samuel BatesHeath-Chiozzi MargoYoung Diane C.Jimenez Freddy A.Lawver Teri L